| Servier (Suisse) SA - Onivyde liposomal pégylé 4.3 mg/ml, dispersion à diluer pour perfusion | | 65994 | | 01 | | Onivyde liposomal pégylé 4.3 mg/ml | | dispersion à diluer pour perfusion | | L01CE02 | | Irinotecan | | 25.07.2017 | | |
| | Zusammensetzung | | irinotecanum 43 mg ut irinotecani sucrosofas corresp. irinotecani hydrochloridum trihydricum 50 mg, 1,2-distearoyl-sn-glycero-3-phosphocholinum, cholesterolum, N-(carbonyl-methoxypolyethylenglycoli 2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolaminum natricum, acidum hydroxyethylpiperazinethansulfonicum, natrii chloridum corresp. natrium 33.1 mg, aqua ad iniectabile q.s. ad solutionem pro 10 ml. | | Packungsbestandteile | | dispersion à diluer pour perfusion | | | | | | Wirkstoffe | Stärke |
|---|
| Irinotecan | 43mg / 10ml |
| | | | Hilfsstoffe |
|---|
| 1,2-distearoyl-Sn-Glycero-3-Phosphocholinum | | Acidum Hydroxyethylpiperazinethansulfonicum | | Cholesterol | | N-(carbonyl-Methoxypolyethylenglycoli 2000)-1,2-distearoyl-Sn-Glycero-3-Phosphoethanolaminum Natricum | | Natrium Chlorid |
|
| | Packungsnummer | Packungsgrösse | EFP | PP | Kat. | SL | In Refdata nicht gelistet |
|---|
| 003 | | PA | PA | A | | Ja |
|
|
